1. The Clinical Outcome Study for dysferlinopathy: An international multicenter study Harris, Elizabeth; Bladen, Catherine L.; Mayhew, Anna; Bettinson, Karen; Moore, Ursula; Smith, Fiona E.; Rufibach, Laura; Cnaan, Avital; Bharucha-Goebel, Diana X.; Blamire, Andrew M.; Bravver, Elena; Carlier, Pierre G.; Day, John W.; Díaz-Manera, Jordi; Eagle, Michelle; Grieben, Ulrike; Harms, Matthew Benjamin; Jones, Kristi J.; Lochmüller, Hanns; Mendell, Jerry R.; Mori-Yoshimura, Madoka; Paradas, Carmen; Pegoraro, Elena; Pestronk, Alan; Salort-Campana, Emmanuelle; Schreiber-Katz, Olivia; Semplicini, Claudio; Spuler, Simone; Stojkovic, Tanya; Straub, Volker; Takeda, Shin’ich; Rocha, Carolina Tesi; Walter, M. C.; Bushby, Kate; The Jain COS Consortium 2016 Articles EpidemiologyMuscular dystrophyGeneticsNeurology
2. Inhibition of extracellular signal-regulated kinase 1/2 signaling has beneficial effects on skeletal muscle in a mouse model of Emery-Dreifuss muscular dystrophy caused by lamin A/C gene mutation Muchir, Antoine; Kim, Young Jin; Reilly, Sarah A.; Wu, Wei; Choi, Jason C.; Worman, Howard J. 2013 Articles Nuclear membranesMuscular dystrophyMuscular dystrophy--Genetic aspectsMitogen-activated protein kinasesMedical sciencesMedicineMicrobiology